Baxter International Inc (BAX) Shares Bought by Chicago Partners Investment Group LLC

Chicago Partners Investment Group LLC grew its holdings in shares of Baxter International Inc (NYSE:BAX) by 31.4% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,351 shares of the medical instruments supplier’s stock after buying an additional 800 shares during the period. Chicago Partners Investment Group LLC’s holdings in Baxter International were worth $225,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the business. FMR LLC boosted its holdings in shares of Baxter International by 25.6% during the 2nd quarter. FMR LLC now owns 28,637,027 shares of the medical instruments supplier’s stock worth $2,114,558,000 after buying an additional 5,845,720 shares in the last quarter. Voya Investment Management LLC boosted its holdings in shares of Baxter International by 411.6% during the 2nd quarter. Voya Investment Management LLC now owns 3,411,849 shares of the medical instruments supplier’s stock worth $251,931,000 after buying an additional 2,745,012 shares in the last quarter. Morgan Stanley boosted its holdings in shares of Baxter International by 107.8% during the 2nd quarter. Morgan Stanley now owns 2,873,253 shares of the medical instruments supplier’s stock worth $212,161,000 after buying an additional 1,490,287 shares in the last quarter. Standard Life Aberdeen plc boosted its holdings in shares of Baxter International by 77.2% during the 2nd quarter. Standard Life Aberdeen plc now owns 2,596,870 shares of the medical instruments supplier’s stock worth $191,753,000 after buying an additional 1,131,691 shares in the last quarter. Finally, Swiss National Bank boosted its holdings in shares of Baxter International by 6.1% during the 2nd quarter. Swiss National Bank now owns 2,191,439 shares of the medical instruments supplier’s stock worth $161,816,000 after buying an additional 125,700 shares in the last quarter. Hedge funds and other institutional investors own 82.28% of the company’s stock.

Shares of BAX opened at $63.48 on Friday. Baxter International Inc has a 12-month low of $61.05 and a 12-month high of $78.38. The company has a current ratio of 2.60, a quick ratio of 2.00 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $33.79 billion, a P/E ratio of 21.82, a PEG ratio of 1.71 and a beta of 1.02.

Baxter International (NYSE:BAX) last issued its earnings results on Wednesday, October 31st. The medical instruments supplier reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.74 by $0.06. Baxter International had a return on equity of 17.67% and a net margin of 10.90%. The company had revenue of $2.77 billion for the quarter, compared to analysts’ expectations of $2.79 billion. During the same period last year, the business earned $0.64 EPS. Baxter International’s quarterly revenue was up 2.2% compared to the same quarter last year. As a group, sell-side analysts forecast that Baxter International Inc will post 3 earnings per share for the current fiscal year.

In other Baxter International news, SVP Giuseppe Accogli sold 17,647 shares of the firm’s stock in a transaction on Monday, September 17th. The stock was sold at an average price of $77.27, for a total transaction of $1,363,583.69. Following the transaction, the senior vice president now directly owns 59,452 shares in the company, valued at approximately $4,593,856.04. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.05% of the stock is currently owned by company insiders.

A number of research firms have issued reports on BAX. Citigroup increased their price target on Baxter International from $74.00 to $76.00 and gave the stock a “neutral” rating in a report on Tuesday, July 31st. Piper Jaffray Companies cut their price target on Baxter International from $83.00 to $72.00 and set an “overweight” rating on the stock in a report on Thursday, November 1st. Leerink Swann cut their price target on Baxter International from $90.00 to $77.00 and set an “outperform” rating on the stock in a report on Thursday, November 1st. BMO Capital Markets cut their price target on Baxter International from $86.00 to $76.00 and set an “outperform” rating on the stock in a report on Thursday, November 1st. Finally, Royal Bank of Canada restated a “hold” rating and set a $76.00 price target on shares of Baxter International in a report on Friday, July 27th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and eleven have issued a buy rating to the company. Baxter International presently has a consensus rating of “Buy” and an average price target of $75.25.

ILLEGAL ACTIVITY NOTICE: “Baxter International Inc (BAX) Shares Bought by Chicago Partners Investment Group LLC” was published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://sportsperspectives.com/2018/11/10/baxter-international-inc-bax-shares-bought-by-chicago-partners-investment-group-llc.html.

About Baxter International

Baxter International Inc provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies.

Recommended Story: How does inflation affect different investments?

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc (NYSE:BAX).

Institutional Ownership by Quarter for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply